Starpharma Holdings (SPL.AX) Earnings Analysis
Starpharma Holdings (SPL.AX) next reports earnings on 2026-08-26. Trailing P/E -90.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SPL.AX next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
SPL.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-17 | 0.003 AUD | n/a | n/a | n/a |
| 2025-02-26 | -0.01296 AUD | n/a | n/a | n/a |
| 2024-10-31 | -0.01729 AUD | n/a | n/a | n/a |
SPL.AX valuation and analyst view
| Trailing P/E | -90.26 |
|---|---|
| Trailing EPS | -0.00771 AUD |
| Price / book | 13.55 |
| Dividend yield | 0.00% |
| Market cap | 0.29B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Starpharma Holdings (SPL.AX)'s next earnings date?
Starpharma Holdings is next scheduled to report on 2026-08-26.
Did SPL.AX beat earnings last quarter?
Consensus estimate data was not available for SPL.AX's 2026-02-17 report.
What is SPL.AX's current P/E ratio and EPS?
SPL.AX trades at a trailing P/E of -90.26 on trailing EPS of -0.007713241108783924 AUD.
What do analysts rate SPL.AX?
SPL.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.